AHPL Generic : Flunisolide
146.25 0.025%w / v / 0.035%w / v / 25mcg 10 ml
â€¢ Most Common:
Nasal irritation, itching, increased cough, nausea, vomiting, sore throat, nasal congestion, sneezing, nasal burning, nosebleed and nasal dryness.
â€¢ Respiratory: Inflammation of pharynx/sinuses and increased cough.
â€¢ ENT: Abnormal sense of smell.
The recommended starting dose is 2 sprays (58 mcg) in each nostril 2 times a day (total dose 232 mcg/day).
It comes as a solution for inhalation.
It is not advisable to administer in patients with infection in the mucus membrane region of the nose; hypersensitivity.
â€¢ Caution should be exercised in patients with history of tuberculosis (TB), fungal or bacterial infections, liver, kidney, intestinal or heart disease, diabetes, decrease in thyroid hormone, osteoporosis, high blood pressure, mental illness, autoimmune neuromuscular disease, inflammation in joints, eye infection, epilepsy and ulcer, during pregnancy and breastfeeding.
â€¢ Avoid contact with your eyes.
â€¢ Avoid contact with people who have infections.
It should be used in regular intervals.
Avoid excess dosage.
Store at 15 to 30Ã‚Â°C. Away from light.